Incidence of Corneal Perforation and Lagophthalmos in Patients with Leprosy in Japan Based on 40-year Observations

Overview

Journal Jpn J Ophthalmol

Specialty Ophthalmology

Date 2025 Jan 3

PMID 39752024

Authors

Takashi Ono

Takuya Iwasaki

Keita Takada

Shota Tokuda

Toshihiro Sakisaka

Yosai Mori

Ryohei Nejima

Masao Kakibuchi

Takashi Miyai

Kazunori Miyata

Affiliations

Soon will be listed here.

Abstract

Purpose: This study aimed to report the incidence, characteristics, and prognosis of corneal perforation in patients with leprosy.

Study Design: Retrospective observational study.

Methods: Patients who presented with leprosy and visited a specialised ophthalmology hospital (Miyata Eye Hospital, Miyazaki, Japan) between 1980 and 2020 were included. Their medical charts were retrospectively reviewed, and the incidence of lagophthalmos and corneal perforation was examined. Additionally, the presentation, treatment, and prognosis of patients with corneal perforations were assessed.

Results: In total, the records of 472 eyes of 236 patients (128 men and 108 women; mean age, 81.2 ± 7.5 years) diagnosed with leprosy were reviewed. Forty-one patients were diagnosed with lagophthalmos, and two of these patients (4.8%) showed signs of corneal perforation. Patients with lagophthalmos presented significantly more frequently with cicatricial contraction of eyelids (p < 0.001), superficial punctate keratopathy (p < 0.001), epithelial defect (p = 0.039), and corneal ulcer (p < 0.001) compared with patients without lagophthalmos. Patients with corneal perforation had uveitis more frequently compared with those without corneal perforation (p = 0.01).

Conclusion: Patients with leprosy frequently develop lagophthalmos. Patients with uveitis associated with leprosy are especially at risk of corneal perforation.

References

Britton W, Lockwood D . Leprosy. Lancet. 2004; 363(9416):1209-19. DOI: 10.1016/S0140-6736(04)15952-7. View

Malik A, Morris R, Ffytche T . The prevalence of ocular complications in leprosy patients seen in the United Kingdom over a period of 21 years. Eye (Lond). 2011; 25(6):740-5. PMC: 3178125. DOI: 10.1038/eye.2011.43. View

Grzybowski A, Nita M, Virmond M . Ocular leprosy. Clin Dermatol. 2014; 33(1):79-89. DOI: 10.1016/j.clindermatol.2014.07.003. View

Pavezzi P, do Prado R, Boin Filho P, Gon A, Tuma B, Fornazieri M . Evaluation of ocular involvement in patients with Hansen's disease. PLoS Negl Trop Dis. 2020; 14(9):e0008585. PMC: 7505469. DOI: 10.1371/journal.pntd.0008585. View

Daniel E, Koshy S, Rao G, Rao P . Ocular complications in newly diagnosed borderline lepromatous and lepromatous leprosy patients: baseline profile of the Indian cohort. Br J Ophthalmol. 2002; 86(12):1336-40. PMC: 1771430. DOI: 10.1136/bjo.86.12.1336. View

Parikh R, Thomas S, Muliyil J, Parikh S, Thomas R . Ocular manifestation in treated multibacillary Hansen's disease. Ophthalmology. 2009; 116(11):2051-7.e1. DOI: 10.1016/j.ophtha.2009.04.021. View

Mpyet C, Solomon A . Prevalence and causes of blindness and low vision in leprosy villages of north eastern Nigeria. Br J Ophthalmol. 2005; 89(4):417-9. PMC: 1772607. DOI: 10.1136/bjo.2004.048777. View

Takahashi S, Ono T, Abe K, Mori Y, Nejima R, Iwasaki T . Prognosis and etiology of traumatic and non-traumatic corneal perforations in a tertiary referral hospital: a 30-year retrospective study. Graefes Arch Clin Exp Ophthalmol. 2021; 260(2):629-635. DOI: 10.1007/s00417-021-05389-5. View

Iraha S, Kondo S, Yamaguchi T, Inoue T . Bilateral corneal perforation caused by neurotrophic keratopathy associated with leprosy: a case report. BMC Ophthalmol. 2022; 22(1):42. PMC: 8800195. DOI: 10.1186/s12886-022-02265-6. View

10.

Courtright P, Daniel E, Sundarrao , Ravanes J, Mengistu F, Belachew M . Eye disease in multibacillary leprosy patients at the time of their leprosy diagnosis: findings from the Longitudinal Study of Ocular Leprosy (LOSOL) in India, the Philippines and Ethiopia. Lepr Rev. 2002; 73(3):225-38. View

11.

Daniel E, Koshy S, Joseph G, Rao P . Ocular complications in incident relapsed borderline lepromatous and lepromatous leprosy patients in south India. Indian J Ophthalmol. 2003; 51(2):155-9. View

12.

Dana M, Hochman M, Viana M, Hill C, Sugar J . Ocular manifestations of leprosy in a noninstitutionalized community in the United States. Arch Ophthalmol. 1994; 112(5):626-9. DOI: 10.1001/archopht.1994.01090170070025. View

13.

Semeraro F, Forbice E, Romano V, Angi M, Romano M, Filippelli M . Neurotrophic keratitis. Ophthalmologica. 2013; 231(4):191-7. DOI: 10.1159/000354380. View

14.

Bonini S, Rama P, Olzi D, Lambiase A . Neurotrophic keratitis. Eye (Lond). 2003; 17(8):989-95. DOI: 10.1038/sj.eye.6700616. View

15.

Karacorlu M, Cakiner T, Saylan T . Corneal sensitivity and correlations between decreased sensitivity and anterior segment pathology in ocular leprosy. Br J Ophthalmol. 1991; 75(2):117-9. PMC: 504128. DOI: 10.1136/bjo.75.2.117. View

16.

Jabbour S, Ashton C, Balal S, Kaye A, Ahmad S . The management of neurotrophic keratitis. Curr Opin Ophthalmol. 2021; 32(4):362-368. DOI: 10.1097/ICU.0000000000000766. View

17.

Rauz S, Koay S, Foot B, Kaye S, Figueiredo F, Burdon M . The Royal College of Ophthalmologists guidelines on serum eye drops for the treatment of severe ocular surface disease: full report. Eye (Lond). 2017; . DOI: 10.1038/eye.2017.209. View